Sigilon Therapeutics ^Investors

Sigilon Therapeutics is a venture capital fund based in Cambridge, Massachusetts, established in 2015 The firm specializes in investing in innovative biotechnology companies that focus on transformative therapies With a significant investment scale of $126 million, Sigilon Therapeutics aims to support the development of groundbreaking solutions in the healthcare sector The fund is committed to advancing scientific research and fostering the growth of its portfolio companies Through strategic investments, Sigilon Therapeutics seeks to enhance patient outcomes and drive progress in the life sciences industry